Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Inclusion Criteria: * Newly diagnosed lung cancer subjects will be stages I-III non-small cell lung cancer (NSCLC) and head and neck cancer subjects will be stages I-IV squamous cell carcinoma (SCC). * Current smokers of combustible cigarettes who smoke \>= 4 days/week. * Lung cancer patients planning to undergo wedge resection surgery for their index cancer. * Head and neck cancer patients planning to undergo surgical resection of their index cancer or exploratory biopsies (tonsil cancer). * Patients must intend to receive ongoing oncology care at Ohio State University \[OSU\] (i.e., their clinic visit is not a consultation/second opinion). * Patients that are over the age of 21 years. Exclusion Criteria: * Patients who are cognitively unable to understand the consent form or participate in interviews. * Patients with hearing impairments. * Patients who are planning to use or are currently using cessation medication to help quit or reduce smoking. * Patients who are currently using e-cigarettes. * Patients undergoing surgery including lobectomy, pneumonectomy, tracheotomy, laryngectomy, or free flap surgery. * Patients with contraindications to per oral intake. * Lung cancer patients who are on home supplemental oxygen at baseline. * Patients that have problems with dexterity that would impact electronic cigarette use. * Patients under 21 years of age. * Patients who don't speak and read English. * Patients with histologies other than NSCLC, or squamous cell carcinoma of …